Steve, it appears that the Cardiac" and "Vascular" cost centers do not generate any "net operating income". At best, if they contribute anything at all to "net operating income", the number is tiny. For several years now, CRY has not been able to increase the gross margin from these two cost centers. Within the past year I seem to recall DAL saying that forward margins would stay about the same. Hence, it appears that these two cost centers are similar to being on a train to no where, as they don't contribute any "net operating income" now, and worse it appears they won't contribute any "net operating income" in the future either. What shareholders want to know is WHY DO YOU CONTINUE TO OPERATE THESE TWO COST CENTERS? It's like the old adage: "You lose money on every sale, but you make it up in volume".
Please don't B S the poor shareholders. With the low stock price they have already suffered enough. All the shareholders want here is an complete clear explanation that tells them the "TRUTH" about why sales that compose 46% of overall sales don't seem to contribute to "net operating income".
Steve, I recently noticed that your base pay went from $1 million in 2012 to $1.13 million in 2013. Also, for 2012 you received 41,667 in free options. For 2013, you received 93,824 in free options. I'm sure you have all sorts of other perks as well. I find it strange that you, and other officers, get paid more while at the same time the stock price continues to struggle. Do the shareholders of CRY ever get a piece of the action, or is that reserved exclusively for you?
Check everything for yourself. Do you own due diligence.